AlzeCure publishes its Annual Report for 2018
AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its Annual Report for 2018 is now available on the company’s website, www.alzecurepharma.se.The information was submitted for publication, through the agency of the contact person set out below at 5.45pm CET on April 15, 2019.
For more information, please contact
Johan Sandin, CEO
Tel: +46 703 738 824
johan.sandin@alzecurepharma.com
About AlzeCure Pharma
AlzeCure Pharma AB is a Swedish pharmaceutical company listed on Nasdaq First North Premier, which engages in innovative pharmaceutical research with a